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The ineffectiveness of individualistic interventions
First, denying clinical treatment to obese patients on grounds 
of their obesity reflects the methodological individualism that 
characterizes dominant approaches to health promotion in 
the US at least (1). As I have argued, such individualism is an 
enormous problem insofar as it is ineffective, is more likely to 
expand health inequalities than an alternative whole population 
approach, and is likely to intensify stigma against obese persons, 
who disproportionately belong to groups that already experience 
higher levels of discrimination and stigma. Rose’s whole 
population approach suggests that making structural changes 
across an entire population is more likely to improve the overall 
health outcomes and compress inequalities than targeting high-
risk groups with individualized health promotion interventions 
(2). 
Eyal acknowledges that a focus on more upstream social 
support is essential, but argues that such “does not touch on the 
question whether policies that engage individual patients and 
their incentives directly make sense as well, alongside these 
social supports” (3).
This is of course logically true; the fact that attention to 
macrosocial determinants of obesity and undernourishment/
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Abstract
I agree entirely with Nir Eyal’s perspective that denying treatment to 
obese patients is morally wrong.  However, the reasons for this belief 
differ in some ways from Eyal’s analysis.  In this commentary, I will 
try to explain the similarities and differences in our perspectives. 
My primary claim is that the denial of treatment to obese patients 
is wrong principally because (i) it eschews a whole-population 
approach to the problem of poor nutrition and is therefore likely to be 
ineffective; (ii) it is likely to expand obesity-related health inequities; 
and (iii) it is likely to intensify stigma against already-marginalized 
social groups.  I shall consider each in turn, and explore the extent to 
which Eyal would be likely to agree with my claims.
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malnutrition may be a preferable public health policy intervention 
to methodologically individualistic approaches does not in and 
of itself demonstrate that the latter is morally wrong.  However, 
the conclusion that individualized interventions are highly 
likely to be ineffective across the target population is not best 
construed as an airtight proof. Such interventions are rather 
ethically deficient, and therefore should receive significantly less 
resources and attention than an alternative whole population 
approach (1). Of course, as Eyal points out, this implies that 
individualized approaches might well have a (small) place in the 
bundle of policies and levers used to diminish obesity incidence 
and prevalence.  Nevertheless, where there is reasonable evidence 
that such individualized approaches to health promotion are 
prioritized in the US at least, such is at the very least ethically 
suboptimal, if not categorically wrong (1).
It is also worth pointing out here that attention to upstream 
macrosocial determinants of poor nutrition is not justified solely 
because doing so constitutes “institutional encouragement of 
healthy individual choices.” Although Eyal does not use the term, 
such resembles descriptions of the so-called “nudge” in public 
health. As Crawshaw has recently pointed out, the problem with 
the nudge is that it remains methodologically individualist (4). 
The end goal remains reform of individual health behaviors rather 
than the structural conditions. The primary normative goal of 
attention to the social determinants of health ought not to be 
seen as the production of less risky individual health behaviors, 
even if the former is likely to have such effects. Although there 
is significant ongoing debate regarding the extent to which 
health behaviors determine health outcomes, (1) there is little 
disagreement that structural conditions affect health outcomes 
in ways beyond their influence on health behaviors.
Individualistic approaches such as denial of treatment may 
expand health inequities
An additional problem with denying treatment to obese patients 
is that such methodologically individualistic interventions are 
significantly more likely than a whole population approach 
to expand obesity-related health inequities. Capewell and 
Graham term methodologically individualistic approaches 
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“agentic” insofar as the extent of benefit capture depends on 
the resources which the individual agent is able to bring to 
bear (5). Unsurprisingly, affluent individuals generally benefit 
more from agentic interventions than the least well-off. Because 
such implies that health inequities between rich and poor will 
increase even if the intervention successfully improves absolute 
health, this is an enormous ethical problem. As applied to the 
case at hand, one would be justified in predicting that the ‘stick’ 
of denying treatment to obese patients is accordingly more likely 
to produce behavior change among the affluent than the poor. 
Unfortunately, a literature search does not reveal studies that 
have directly evaluated this hypothesis.
Eyal cites Sir Michael Marmot for the same point, but argues 
that “when unhealthy choices are more common among the 
poorer or less educated... then the collective positive impact on 
the poor and less educated could remain greater than the one on 
the rich and educated.”  I either do not understand this claim 
or do not agree with it.  First, it is unclear how Eyal construes 
“collective positive impact,” which matters morally because one 
of the fighting issues is the extent to which we should permit 
an expansion of socioeconomic status (SES)-related inequities 
if such includes a small absolute improvement in health among 
the least well-off. Thus, it does not follow from the mere 
fact that the least well-off obtain any health benefit from an 
agentic obesity intervention that such intervention is morally 
permissible. Second, it is of course possible that the collective 
positive impact could be greater for the least well-off than that 
enjoyed by the affluent, but Marmot’s (and my) point is precisely 
that the weight of the evidence suggests that such an occurrence 
is unlikely via an agentic approach. And although the question 
itself awaits a full empirical assessment, there is little justification 
for predicting as such regarding obesity when the evidentiary 
trends for other agentic interventions in public health contexts 
suggest the contrary (5,6). 
Denial of treatment may intensify the stigma
The third and arguably most morally problematic aspect 
of denying treatment to obese patients is the likelihood that 
doing so may intensify stigma against already-marginalized 
populations. Although of course individuals may experience 
stigma, it is most accurately understood as a group-level 
phenomenon.  In public health contexts, stigma is defined by an 
in-group’s assessment of difference on the basis of an identifiable 
characteristic shared among the out-group, and then by the in-
group’s assignation of deviance to the out-group on the basis of 
that characteristic (7,8).  Because the in-group must by definition 
be enfranchised (otherwise it would be unable to mark the out-
group as different and attribute deviance), stigma is inextricably 
linked to structures of power and privilege.
Moreover, the focus on individual responsibility for health has 
a long history in American culture, and there is little dispute 
that it remains a powerful framework through which notions 
of desert and culpability are assigned to illness sufferers in the 
US (1). By virtue of their relentless focus on the individual, 
agentic interventions are as a category more likely to intensify 
stigma (1). This is especially problematic insofar as risky health 
behaviors are disproportionately prevalent among the least well-
off.  This means that health stigma is more likely to be directed 
at the least well-off, who are already more likely to experience 
stigma and discrimination in their respective social lives.
There is a sense in which denying treatment to obese persons 
exacerbates the moral problem. Exhorting the most materially 
deprived to consume less sugar-sweetened beverages may in 
general be more likely to create or intensify pre-existing stigma, 
but it nevertheless seems qualitatively different from the denial 
of service at issue in the present case. And where such denial is 
disproportionately more likely to be directed at groups who have 
historically been disenfranchised and denied from services, the 
denial of treatment becomes increasingly difficult to defend. 
Note that this is a normative critique, and does not even address 
the overwhelming evidence that stigmatizing obese persons is 
not only likely to be ineffective, but may actually worsen obesity. 
Eyal agrees that the specter of obesity stigma is “substantial,” 
although his commentary does not emphasize the moral 
problems raised by stigma (9).
Conclusion
Ultimately, Eyal and I agree that the denial of treatment to 
obese persons is morally illegitimate, although our rationales 
for thinking so are at least somewhat different.  Perhaps the 
takeaway is that there is a plethora of reasons to find the practice 
morally dubious. Other public health policy responses to the 
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